U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477639) titled 'Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis' on March 09.
Brief Summary: The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called primary progressive or secondary progressive MS.
The main questions the trial aims to answer are the following:
* Is TRX319 safe when administered to patients with progressive forms of MS?
* At what dose does TRX319 work the best to treat participants with primary and or secondary progressive MS?
* Is pre-conditioning (with Bendamustine) needed to allow TRX319 to better treat participants with prim...